Simplex Trading’s Oruka Therapeutics ORKA Stock Holding History

Simplex Trading’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,463	Closed	-$164K	–	10531
2026 Q1	$121K	Buy	+2,463	New	+$85.6K	﹤0.01%	4867
2025 Q4	–	Sell	-729	Closed	-$20.3K	–	10414
2025 Q3	$14K	Buy	+729	New	+$10.8K	﹤0.01%	7674
2024 Q3	–	Sell	-23	Closed	-$1K	–	9789
2024 Q2	$1K	Buy	+23	New	+$917	﹤0.01%	8608
2024 Q1	–	Sell	-8	Closed	-$159	–	10109
2023 Q4	$0	Buy	+8	New	+$180	﹤0.01%	10033
2022 Q4	–	Sell	-43	Closed	-$1.1K	–	10674
2022 Q3	$1K	Buy	+43	New	+$1.22K	﹤0.01%	9691
2022 Q2	–	Sell	-217	Closed	-$6.13K	–	11319
2022 Q1	$5K	Sell	217 -1,048	-83%	-$26K	﹤0.01%	9471
2021 Q4	$32K	Buy	1,265 +1,159	+1,093%	+$34.9K	﹤0.01%	7827
2021 Q3	$4K	Buy	+106	New	+$3.92K	﹤0.01%	9371
2021 Q2	–	Sell	-927	Closed	-$38.7K	–	10836
2021 Q1	$40K	Buy	927 +898	+3,097%	+$47.1K	﹤0.01%	6868
2020 Q4	$1K	Buy	+29	New	+$1.44K	﹤0.01%	8176

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Simplex Trading's ORKA Position: Q2 2026 in Review

Simplex Trading sold out of Oruka Therapeutics (ORKA) in Q2 2026, closing a stake of 2,463 shares — an estimated $164K sold.

Simplex Trading first reported a position in ORKA in Q4 2020 and held it in 10 quarters. The position peaked at $121K in Q1 2026. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Simplex Trading reported no remaining Oruka Therapeutics position as of Q2 2026 after selling out during the quarter.
Simplex Trading sold 2,463 Oruka Therapeutics shares in Q2 2026, an estimated $164K.
Simplex Trading first reported a position in Oruka Therapeutics in Q4 2020 and held it in 10 quarters.
Simplex Trading's Oruka Therapeutics position peaked at $121K in Q1 2026.
256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.